Showing 23 results for Cardiovascular
Rasoul Soleimani Moghadam, Shabnam Mohammadi , Nayereh Kargar Kakhki , Maryam Mohammadi, Abolfazl Ghadimifar , Abolfazl Ahmadnejad , Atefeh Talaei Bagestani , Mahmoud Reza Nemat Allahi , Alireza Mohammadzadeh , Majid Ghayour Mobarhan, Fatemeh Mohammadzadeh ,
Volume 17, Issue 3 (3-2018)
Abstract
Background: According to the World Health Organization, cardiovascular diseases are the leading cause of death. Behavior modification to improve lifestyle habits can reduce the risk of cardiovascular disease. The aim of this study was to investigate the health promoting lifestyle in Patients with cardiovascular disease in 2014.
Methods: After approval of the study, 352 patients with cardiovascular disease in Gonabad city were enrolled 2014. Data were collected using Health Promoting Lifestyle Promoting (HPLP2) questionnaire. Then analyzed using SPSS software and the Mann-Whitney and Kruskal-Wallis tests. The significance level of P value was considered to be less than 0.05.
Results: Three hundred and fifty-two patients (232 females and 120 males) were recruited, with a mean age of 61.89 ± 1.34 years. The highest mean score of lifestyle was 24.45 ± 8.05 in personal relationships and the lowest was 12.65 ± 5.60 in the area of stress management. All structures had the direct impact on the lifestyle that the most direct impact was social relations (R2= 0.329) and the least direct impact was stress management (R2= 0.164) and the strongest predictor of lifestyle in the mechanisms related to physical activity with the overall effect 14.38 was based on the pattern walker.
Conclusion: Considering, life style has a significant effect on cardiovascular disease. It is possible to improve the lifestyle of patients by providing steps to prevent and control this disease.
Esmail Shekari, Seyed Kianoosh Hosseini, Farideh Razi, Ensieh Nasli Esfahani, Mostafa Qorbani, Bagher Larijani,
Volume 19, Issue 4 (4-2020)
Abstract
Background: Diabetes mellitus is one of the most common endocrine diseases. Cardiovascular disease (CVD) is one of the leading causes of death in patients with type 2 diabetes. The aim of this study was to investigate the metabolic profile of plasma amino acids in diabetic patients with cardiovascular disease.
Methods: The present study is a descriptive-analytical cross-sectional study on 140 patients including 35 patients with type 2 diabetes and cardiovascular disease (CVD.DM), 35 patients with type 2 diabetes and non-cardiovascular disease (DM). 35 non-diabetic patients with cardiovascular disease (CVD.nDM) and 35 non-diabetic patients with non-cardiovascular disease (HS) were referred to Diabetes Clinic No. 1 of Tehran University of Medical Sciences.
Results: 76 (54.3%) were male and 64 (45.7%) were female. The highest concentrations of glutamine and isoleucine were observed in DM.CVD, asparagine, serine, arginine, threonine, alanine, tyrosine, valine in DM.nCVD and methionine in CVD.nDM. The lowest concentrations of tyrosine and tryptophan in DM.CVD has been detected , and methionine has been detected in DM.nCVD. The amino acids alanine, glutamine, tyrosine, valine, methionine, leucine, lysine and arginine significantly increased the chances of developing DM.nCVD. For each increase in Z-score per plasma concentration of isoleucine, the chances of developing cardiovascular disease without diabetes were significantly increased.
Conclusion: The amino acids alanine, glutamine, tyrosine, valine, methionine, leucine, lysine and arginine are involved in predicting the risk of DM.nCVD and isoleucine and methionine are involved in predicting the risk of CVD.nDM.
Mousa Khalafi, Amir Ghanbarpour Nosrati, Keyvan Sharifmoradi,
Volume 23, Issue 4 (11-2023)
Abstract
Background: Fetuin-A, as a hepatokine, plays an important role in the regulation of whole-body metabolism, which is increased with chronic diseases. Therefore, the aim of this meta-analysis is to investigate the effect of exercise training on Fetuin-A levels in individuals with metabolic and kidney diseases.
Methods: A systematic search was conducted in PubMed, Web of Science, and Google Scholar databases until November 2022 using the keywords "exercise training" and "Fetuin-A". To determine the effect size, standardized mean difference (SMD) and 95% confidence interval were calculated using CMA2 software. Heterogeneity was evaluated using the I2 test, and publication bias was evaluated by visual interpretation of the funnel plot and Egger's test. The quality of the included studies was evaluated using the PEDRO checklist.
Results: A total of 16 studies including 21 trials arms and 554 subjects with type 2 diabetes, obesity and kidney disease were included in the meta-analysis. Exercise training resulted in a significant decrease in Fetuin-A levels [-0.93 (CI: -1.35 to -0.51) P= 0.001]. There was a high heterogeneity (I2= 89.24, P= 0.001) and also a significant publication bias (P= 0.001). The results of subgroup analysis based on the type of exercise training showed that aerobic training resulted in a significant decrease in Fetuin-A (P= 0.001) while the reduction of this marker with combined training was not significant (P= 0.33).
Conclusion: Exercise training, especially aerobic training, results in a decrease in Fetuin-A levels in metabolic patients, which may be contributed to the beneficial effects of exercise.
